Calmar Pain Relief, LLC

Calmar Pain Relief Therapy (CPR-T) is a revolutionary, non-invasive, non-narcotic method for rapid treatment of severe, chronic, high-intensity oncologic, and neuropathic pain, resistant to morphine and other drugs. CPR-T treats pain through a biophysical rather a than biochemical process. During treatments pain is completely removed, regardless of pain intensity. With subsequent treatments, pain recurs with diminishing intensity until it disappears in a high percentage of cases. The cutting edge, technological medical device was developed from the research of Professor Giuseppe Marineo MD, a researcher and bioengineer, founder & manager of Delta Research & Development. Delta R&D is the medical Bioengineering Research Centre affiliated with Tor Vergata University of Rome, Italy. When receiving Calmar Pain Relief Therapy (CPR-T), artificial neurons are created to non-invasively transmit to the central nervous system (CNS) information that is recognizable as ‘self’ and ‘non-pain’ through surface receptors on the skin. Compared to conventional electro-analgesia, the CPR-T principle substitutes pain information with synthetic ‘non-pain’ information, rather than blocking pain transmission as with TENS or implanted devices utilizing the Gate Control theory. The device incorporates electromedical equipment for electronic nerve stimulation, and uses the nerve fiber as a passive means to convey a message of normality to the central nervous system by a procedure defined as “Scrambling” or tricking of information, which then enables the central nervous system to modify the reflex adaptive responses. Various clinical indications that have been successfully treated include: • Neuropathic, oncologic visceral pain • Severe chronic pain that is non-responsive to pharmaceutical treatment or implanted devices, including TENS

Medical Practice
West Warwick, Rhode Island
Founded in unknown
1-10 employees

Calmar Pain Relief Therapy (CPR-T) is a revolutionary, non-invasive, non-narcotic method for rapid treatment of severe, chronic, high-intensity oncologic, and neuropathic pain, resistant to morphine and other drugs. CPR-T treats pain through a biophysical rather a than biochemical process. During treatments pain is completely removed, regardless of pain intensity. With subsequent treatments, pain recurs with diminishing intensity until it disappears in a high percentage of cases. The cutting edge, technological medical device was developed from the research of Professor Giuseppe Marineo MD, a researcher and bioengineer, founder & manager of Delta Research & Development. Delta R&D is the medical Bioengineering Research Centre affiliated with Tor Vergata University of Rome, Italy. When receiving Calmar Pain Relief Therapy (CPR-T), artificial neurons are created to non-invasively transmit to the central nervous system (CNS) information that is recognizable as ‘self’ and ‘non-pain’ through surface receptors on the skin. Compared to conventional electro-analgesia, the CPR-T principle substitutes pain information with synthetic ‘non-pain’ information, rather than blocking pain transmission as with TENS or implanted devices utilizing the Gate Control theory. The device incorporates electromedical equipment for electronic nerve stimulation, and uses the nerve fiber as a passive means to convey a message of normality to the central nervous system by a procedure defined as “Scrambling” or tricking of information, which then enables the central nervous system to modify the reflex adaptive responses. Various clinical indications that have been successfully treated include: • Neuropathic, oncologic visceral pain • Severe chronic pain that is non-responsive to pharmaceutical treatment or implanted devices, including TENS

Company Information

Industry
Medical Practice
Company Type
Privately Held
Founded
unknown
Employee Range
1-10
Revenue Range
Not available

Location

Address
1637 Mineral Spring Ave., Suite 111B RI North Providence
City
West Warwick
Region
Rhode Island
Postal Code
02904
Country
United States

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions